Contribution of the ade resistance-nodulation-cell division-type efflux pumps to fitness and pathogenesis of Acinetobacter baumannii

mBio

Volumn 7, Issue 3, 2016, Pages

  Yoon, Eun Jeong ^a   Balloy, Viviane ^b,c   Fiette, Laurence ^a   Chignard, Michel ^b,c   Courvalin, Patrice ^a   Grillot Courvalin, Catherine ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADEABC PROTEIN; RESISTANCE NODULATION CELL DIVISION TYPE EFFLUX PUMP; UNCLASSIFIED DRUG; ADEA PROTEIN, ACINETOBACTER BAUMANNII; ADEB PROTEIN, ACINETOBACTER BAUMANNII; ADEC PROTEIN, ACINETOBACTER BAUMANNII; BACTERIAL PROTEIN; CARRIER PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LUNG INFECTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOFILM; CELL DIVISION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEUTROPHIL; PATHOGENICITY; PATHOLOGY; REPRODUCTIVE FITNESS; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CELL DIVISION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENETIC FITNESS; HUMANS; IMMUNOCOMPETENCE; LUNG; MEMBRANE TRANSPORT PROTEINS; MICE; NEUTROPHILS; VIRULENCE;

EID: 84978955025     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00697-16     Document Type: Article

References (35)

1. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939-951. http://dx.doi.org/10.1038/nrmicro1789.
2. Coyne S, Courvalin P, Périchon B. 2011. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55: 947-953. http://dx.doi.org/10.1128/AAC.01388-10.
3. Magnet S, Courvalin P, Lambert T. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 45: 3375-3380. http://dx.doi.org/10.1128/AAC.45.12.3375-3380.2001.
4. Coyne S, Rosenfeld N, Lambert T, Courvalin P, Périchon B. 2010. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 54:4389-4393. http://dx.doi.org/10.1128/AAC.00155-10.
5. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P. 2008. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 52: 557-562. http://dx.doi.org/10.1128/AAC.00732-07.
6. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. 2004. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 48:3298-3304. http://dx.doi.org/10.1128/AAC.48.9.3298-3304.2004.
7. Rosenfeld N, Bouchier C, Courvalin P, Périchon B. 2012. Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator. Antimicrob Agents Chemother 56:2504-2510. http://dx.doi.org/10.1128/AAC.06422-11.
8. Yoon EJ, Courvalin P, Grillot-Courvalin C. 2013. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother 57:2989-2995. http://dx.doi.org/10.1128/AAC.02556-12.
9. Yoon EJ, Chabane YN, Goussard S, Snesrud E, Courvalin P, Dé E, Grillot-Courvalin C. 2015. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. mBio 6:e00309-15. http://dx.doi.org/10.1128/mBio.00309-15.
10. Rumbo C, Gato E, López M, Ruiz de Alegría C, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Pachón J, Cisneros JM, Rodríguez-Baño J, Pascual A, Bou G, Tomás M, Spanish Group of Nosocomial Infections and Mechanisms of Action and Resistance to Antimicrobials (GEIHGEMARA), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). 2013. Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 57:5247-5257. http://dx.doi.org/10.1128/AAC.00730-13.
11. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8:260-271. http://dx.doi.org/10.1038/nrmicro2319.
12. Piddock LJ. 2006. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4:629-636. http://dx.doi.org/10.1038/nrmicro1464.
13. Nishino K, Latifi T, Groisman EA. 2006. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimu-rium. Mol Microbiol 59:126-141. http://dx.doi.org/10.1111/j.1365-2958.2005.04940.x.
14. Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, Kamihira S, Hancock RE, Speert DP. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med 196:109-118. http://dx.doi.org/10.1084/jem.20020005.
15. Padilla E, Llobet E, Doménech-Sánchez A, Martínez-Martínez L, Bengoechea JA, Albertí S. 2010. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54:177-183. http://dx.doi.org/10.1128/AAC.00715-09.
16. Pérez A, Poza M, Fernández A, del Carmen Fernández M, Mallo S, Merino M, Rumbo-Feal S, Cabral MP, Bou G. 2012. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 56:2084-2090. http://dx.doi.org/10.1128/AAC.05509-11.
17. Warner DM, Folster JP, Shafer WM, Jerse AE. 2007. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J Infect Dis 196:1804-1812. http://dx.doi.org/10.1086/522964.
18. Alonso A, Morales G, Escalante R, Campanario E, Sastre L, Martinez JL. 2004. Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother 53: 432-434. http://dx.doi.org/10.1093/jac/dkh074.
19. Olivares J, Alvarez-Ortega C, Linares JF, Rojo F, Köhler T, Martínez JL. 2012. Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ Microbiol 14:1968-1981. http://dx.doi.org/10.1111/j.1462-2920.2012.02727.x.
20. McConnell MJ, Actis L, Pachón J. 2013. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 37:130-155. http://dx.doi.org/10.1111/j.1574-6976.2012.00344.x.
21. de Breij A, Eveillard M, Dijkshoorn L, van den Broek PJ, Nibbering PH, Joly-Guillou ML. 2012. Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One 7:e30673. http://dx.doi.org/10.1371/journal.pone.0030673.
22. van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W. 2007. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 75: 5597-5608. http://dx.doi.org/10.1128/IAI.00762-07.
23. Wang N, Ozer EA, Mandel MJ, Hauser AR. 2014. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. mBio 5:e01163-14. http://dx.doi.org/10.1128/mBio.01163-14.
24. Breslow JM, Meissler JJ, Jr, Hartzell RR, Spence PB, Truant A, Gaughan J, Eisenstein TK. 2011. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infect Immun 79:3317-3327. http://dx.doi.org/10.1128/IAI.00069-11.
25. López-Rojas R, McConnell MJ, Jiménez-Mejías ME, Domínguez-Herrera J, Fernández-Cuenca F, Pachón J. 2013. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. Antimicrob Agents Chemother 57:4587-4589. http://dx.doi.org/10.1128/AAC.00543-13.
26. Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, Mekalanos JJ, Lory S, Pier GB, Skurnik D. 2015. Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med 7:297ra114. http://dx.doi.org/10.1126/scitranslmed.aab1621.
27. Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE. 2013. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. J Infect Dis 208:1142-1151. http://dx.doi.org/10.1093/infdis/jit293.
28. Touchon M, Cury J, Yoon EJ, Krizova L, Cerqueira GC, Murphy C, Feldgarden M, Wortman J, Clermont D, Lambert T, Grillot-Courvalin C, Nemec A, Courvalin P, Rocha EP. 2014. The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences. Genome Biol Evol 6:2866-2882. http://dx.doi.org/10.1093/gbe/evu225.
29. Gebhardt MJ, Gallagher LA, Jacobson RK, Usacheva EA, Peterson LR, Zurawski DV, Shuman HA. 2015. Joint transcriptional control of virulence and resistance to antibiotic and environmental stress in Acinetobacter baumannii. mBio 6:e01660-15. http://dx.doi.org/10.1128/mBio.01660-15.
30. Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB. 2013. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci U S A 110: 20747-20752. http://dx.doi.org/10.1073/pnas.1221552110.
31. Marks M, Burns T, Abadi M, Seyoum B, Thornton J, Tuomanen E, Pirofski LA. 2007. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun 75:1586-1597. http://dx.doi.org/10.1128/IAI.01579-06.
32. Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, Chignard M. 2008. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol 181:586-592. http://dx.doi.org/10.4049/jimmunol.181.1.586.
33. Coyne S, Guigon G, Courvalin P, Périchon B. 2010. Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob Agents Chemother 54: 333-340. http://dx.doi.org/10.1128/AAC.01037-09.
34. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial disk susceptibility tests. M02-A12. Clinical and Laboratory Standards Institute, Wayne, PA.
35. Foucault ML, Depardieu F, Courvalin P, Grillot-Courvalin C. 2010. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A 107:16964-16969. http://dx.doi.org/10.1073/pnas.1006855107.